Advertisement
Screener

VIEMED HEALTHCARE, INC. (VMD) Graph

VMD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $78.10M; Cost of revenue $33.05M; Research and development $504.00K; Selling, general and administrative $37.13M.
  • 2026-03-31: Revenue $75.41M; Cost of revenue $32.59M; Research and development $579.00K; Selling, general and administrative $34.79M.
  • 2025-12-31: Revenue $76.18M*; Cost of revenue $32.08M*; Research and development $598.00K*; Selling, general and administrative $32.22M*.
  • 2025-09-30: Revenue $71.91M; Cost of revenue $30.57M; Research and development $775.00K; Selling, general and administrative $31.92M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Service$6.31MEquipment Sales$18.97MRevenue$78.10MCost of revenue$33.05MGross profit$45.05MOperating income$4.46MOther income, net$67.00KResearch & development$504.00KSelling, general& administrative$37.13MPre-tax income$4.05MIncome tax$1.15M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$78.10M$33.05M$504.00K$37.13M$1.15M$2.76M
2026-03-31$75.41M$32.59M$579.00K$34.79M$1.28M$2.58M
2025-12-31$76.18M*$32.08M*$598.00K*$32.22M*$2.19M*$6.11M*
2025-09-30$71.91M$30.57M$775.00K$31.92M$1.53M$3.51M
2025-06-30$63.06M$26.32M$847.00K$28.80M$1.71M$3.16M
2025-03-31$59.13M$25.85M$797.00K$28.43M$952.00K$2.63M
2024-09-30$58.00M$23.63M$757.00K$26.67M$1.59M$3.88M
2024-06-30$54.97M$22.07M$758.00K$26.50M$768.00K$1.47M
2024-03-31$50.59M$20.79M$750.00K$24.81M$518.00K$1.60M
2023-09-30$49.40M$18.84M$593.00K$23.65M$1.32M$2.92M
2023-06-30$43.31M$17.20M$758.00K$20.56M$728.00K$2.33M
2023-03-31$39.56M$15.55M$780.00K$19.76M$501.00K$1.52M
2022-09-30$35.76M$14.11M$670.00K$17.68M$456.00K$1.05M
2022-06-30$33.31M$12.92M$672.00K$17.54M$421.00K$967.00K
2022-03-31$32.26M$12.51M$632.00K$15.78M$745.00K$1.76M
2021-09-30$29.29M$10.90M$576.00K$13.26M$1.39M$1.79M
2021-06-30$27.40M$9.77M$583.00K$12.88M$1.25M$1.57M
2021-03-31$28.42M$10.67M$339.00K$14.51M-$223.00K$1.68M
2020-12-31$31.20M(m)(m)(m)(m)$5.07M
2020-09-30$33.45M$13.99M$243.00K$13.55M$1.14M$2.80M
2020-06-30$42.85M$16.93M$271.00K$16.43M-$6.65M$19.41M
2020-03-31$23.81M$8.25M$174.00K$10.58M$187.00K$4.24M
2019-12-31$21.45M(m)(m)(m)(m)$2.39M
2019-09-30$20.37M$6.32M$208.00K$10.23M$51.00K$2.85M
2019-06-30$20.32M$5.69M$203.00K$11.52M$24.00K$1.33M
2019-03-31$18.11M$5.04M$234.00K$9.46M$138.00K$1.96M
2018-12-31$18.36M$4.84M$0.00$9.70M$127.00K$2.97M
2018-09-30$16.93M$4.10M$0.00$9.46M$35.00K$2.22M
2018-06-30$15.21M$4.18M$0.00$7.89M$0.00$2.10M
2018-03-31$13.96M$3.56M$0.00$7.26M$0.00$2.22M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$153.51M$65.64M$1.08M$71.92M$2.43M$5.35M
2025-06-30$122.19M$52.17M$1.64M$57.23M$2.67M$5.78M
2024-06-30$105.56M$42.86M$1.51M$51.32M$1.29M$3.07M
2023-06-30$82.87M$32.76M$1.54M$40.33M$1.23M$3.85M
2022-06-30$65.56M$25.43M$1.30M$33.31M$1.17M$2.73M
2021-06-30$55.81M$20.45M$922.00K$27.39M$1.02M$3.25M
2020-06-30$66.66M$25.18M$445.00K$27.00M-$6.46M$23.66M
2019-06-30$38.44M$10.73M$437.00K$20.98M$162.00K$3.28M
2018-06-30$29.62M$7.74M$0.00$15.21M$0.00$4.71M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-30$194.10M$82.74M$2.42M$89.15M$4.20M$9.29M
2024-09-30$163.56M$66.50M$2.27M$77.99M$2.88M$6.95M
2023-09-30$132.27M$51.60M$2.13M$63.98M$2.55M$6.77M
2022-09-30$101.32M$39.54M$1.97M$50.99M$1.62M$3.78M
2021-09-30$85.10M$31.35M$1.50M$40.65M$2.41M$5.04M
2020-09-30$100.11M$39.17M$688.00K$40.55M-$5.32M$26.46M
2019-09-30$58.81M$17.05M$645.00K$31.21M$213.00K$6.14M
2018-09-30$46.78M$11.85M$0.00$24.70M$35.00K$7.13M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-31$270.28M$114.82M$3.02M$121.37M$6.39M$15.40M
2024-12-31$224.26M$91.05M$3.07M$106.20M$4.76M$11.40M
2023-12-31$183.01M$70.22M$2.78M$87.88M$4.15M$10.20M
2022-12-31$138.83M$54.15M$2.70M$68.16M$2.77M$6.20M
2021-12-31$117.06M$43.65M$2.11M$54.89M$3.38M$9.13M
2020-12-31$131.31M$51.20M$1.08M$52.83M-$5.17M$31.53M
2019-12-31$80.26M$24.25M$848.00K$41.38M$271.00K$8.53M
2018-12-31$64.46M$16.69M$0.00$34.30M$162.00K$9.51M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
agilon health, inc. (AGL)United States$1.272B-7.76
Progyny, Inc. (PGNY)United States$1.994B28.37
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80